Liminatus Pharma, Inc. - Class A Common Stock

Share · US53271X1081 · LIMN (XNAS)

No Price

03.02.2026 14:44

Current Prices from Liminatus Pharma, Inc. - Class A Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	LIMN	USD	03.02.2026 14:44	0,73 USD	0,14 USD +24,32 %

Share Float & Liquidity

Free Float 46,02 %

Shares Float 12,46 M

Shares Outstanding 27,06 M

Company Profile for Liminatus Pharma, Inc. - Class A Common Stock Share

Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.

AI Analysis of Liminatus Pharma, Inc. - Class A Common Stock

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of Liminatus Pharma, Inc. - Class A Common Stock

No AI threads available for this company yet.

Company Data

Name Liminatus Pharma, Inc. - Class A Common Stock

Company Liminatus Pharma, Inc. Class A Common Stock

Symbol LIMN

Website https://liminatuspharma.com

Primary Exchange

NASDAQ

ISIN US53271X1081

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Chris Kim

Market Capitalization 15 Mio

Country United States of America

Currency USD

Employees 0,0 T

Address 6 Centerpointe Drive, 90623 La Palma

IPO Date 2025-05-01

Ticker Symbols

Name	Symbol
NASDAQ	LIMN

More Shares

Investors who hold Liminatus Pharma, Inc. - Class A Common Stock also have the following shares in their portfolio:

AUSTRALIA & NEW ZEALAND BANKING GROUP LD CALL ZERO CPN NTS 28/03/43 Bond

NRW STAEDTE ANL.3 15/22 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog